What is UltraVision?
UltraVision Corporation is a specialized entity focused on the design, manufacturing, and marketing of advanced ultrasound systems. Catering to both clinical applications and research endeavors, the company's product suite adheres to stringent ISO 13485 standards and boasts FDA 510K approval, ensuring superior ultrasound image quality. UltraVision serves a diverse clientele, including Original Equipment Manufacturers (OEMs), and possesses the capability to execute both bespoke design projects and high-volume system production. Their innovative approach integrates standard PC technology with sophisticated interfaces, making their ultrasound solutions accessible and adaptable across various medical disciplines such as musculoskeletal, endocrinology, and vascular imaging.
How much funding has UltraVision raised?
UltraVision has raised a total of $302K across 2 funding rounds:
Debt
$150K
Debt
$152K
Debt (2020): $150K with participation from PPP
Debt (2021): $152K led by PPP
What's next for UltraVision?
With substantial backing and a clear strategic direction, UltraVision is poised for accelerated growth. The company's late-stage funding context suggests a focus on scaling operations, expanding market reach, and potentially investing in further research and development to maintain its competitive edge. Strategic partnerships and continued innovation in ultrasound technology are anticipated as UltraVision leverages this capital to solidify its leadership in the medical imaging industry, particularly within the OEM segment and specialized clinical fields.
See full UltraVision company page
